BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16642488)

  • 1. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly.
    Otsubo K; Kanegane H; Nomura K; Ogawa J; Miyawaki T; Kunishima S
    Pediatr Blood Cancer; 2006 Dec; 47(7):968-9. PubMed ID: 16642488
    [No Abstract]   [Full Text] [Related]  

  • 2. First description of somatic mosaicism in MYH9 disorders.
    Kunishima S; Matsushita T; Yoshihara T; Nakase Y; Yokoi K; Hamaguchi M; Saito H
    Br J Haematol; 2005 Feb; 128(3):360-5. PubMed ID: 15667538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].
    Kimura N; Matsumoto M; Matsumoto K; Asai N; Kunishima S
    Rinsho Ketsueki; 2008 Dec; 49(12):1614-8. PubMed ID: 19110523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
    Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
    Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the first in cis mutations in MYH9 disorder.
    Miyajima Y; Kunishima S
    Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and molecular-biological study of a May-Hegglin anomaly family].
    Shao XR; Li JZ; Ma J; Zhan ZM; Liang H; She XN; Lu HL; Wang LC; Jia CM; Wu LJ; Jin MH; Chen LJ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):548-51. PubMed ID: 15569536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
    Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
    J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [May-Hegglin anomaly--from genome research to clinical laboratory].
    Kunishima S
    Rinsho Byori; 2003 Sep; 51(9):898-904. PubMed ID: 14560660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
    Kunishima S; Hirano K; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
    [No Abstract]   [Full Text] [Related]  

  • 12. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
    Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. May-Hegglin anomaly: morphologic and clinical manifestations.
    Saito H; Kunishima S
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):111-3. PubMed ID: 19367252
    [No Abstract]   [Full Text] [Related]  

  • 14. [A non-familial May-Hegglin anomaly accompanying with MYH9 gene R1933X mutation and I1626V polymorphism].
    Li Y; Wang YW; Zhang GS; Fang MY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):577-81. PubMed ID: 19954613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique immunofluorescence method promotes accurate diagnosis in MYH9 disorders: a case report.
    Yoshinari M; Kunishima S; Miyabayashi S; Saito H; Tsuchiya S
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):579-83. PubMed ID: 15342975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of MYH9 gene mutation in a May-Hegglin anomaly family].
    Gao F; Hao JH; Wang ZL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):660-2. PubMed ID: 23134864
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocytopenia or giant platelets?
    Fabry U; Lammert F; Osieka R
    Lancet; 2003 Mar; 361(9359):735. PubMed ID: 12620737
    [No Abstract]   [Full Text] [Related]  

  • 18. The first report of homozygous May-Hegglin anomaly E1841K mutation.
    Poopak B; Rezvani H; Difeo A; Martignetti JA; Khosravipour G; Yousefian A; Farahani K; Haghnejad Doshanlo F; Saki N
    Eur J Haematol; 2011 Apr; 86(4):357. PubMed ID: 21083612
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrothrombocytopenia With Congenital Bilateral Cataracts: A Phenotype of MYH9 Disorder With Exon 24 Indel Mutations.
    Aoki T; Kunishima S; Yamashita Y; Minamitani K; Ota S
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):76-78. PubMed ID: 29200148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of nonmuscle mysin heavy chain 9 gene mutation in a May-Hegglin anomaly family].
    Zhang G; Yi Y; Xu M; Ling Z
    Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(13):918-20. PubMed ID: 12126520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.